AMGEN INC is 100.7x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($191.70 B vs $1.90 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADMA | AMGN |
|---|---|---|
| Market cap | $1.90 B | $191.70 B |
| US-listed rank | #2141 | #79 |
| Revenue (latest FY) | $510.17M | $36.75B |
| Net income (latest FY) | $146.93M | $7.71B |
| Net margin | 28.8% | 21.0% |
| P/E (trailing FY) | 13.0 | 24.9 |
| SEC filings | 988 | 1,011 |
AMGEN INC is 100.7x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($191.70 B vs $1.90 B).
In their latest fiscal years, ADMA BIOLOGICS, INC. reported $510.17M in revenue while AMGEN INC reported $36.75B.
Full pages: ADMA BIOLOGICS, INC. and AMGEN INC, or browse the full rankings.